Analgesic effects of fibroblast growth factor in the rat

Neuroscience Letters

Volumn 207, Issue 3, 1996, Pages 175-178

  Cuevas, Pedro ^a   Prieto, Raquel ^a   Saenz De Tejada, Iñigo ^a   Giménez Gallego, Guillermo ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Analgesia; Fibroblast growth factor; Peripheral administration; Rat

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANALGESIC AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 0029963203     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12526-X     Document Type: Article

References (28)

1. Baird, A. and Böhlen, P., Peptide growth factors and their receptors. In M.B. Sporn and A.B. Roberts (Eds.), Handbook of Experimental Pharmacology, Springer-Verlag, Berlin, 1990, pp. 365-418.
2. Chadi, G., Tinner, B., Agnati, L.F. and Fuxe, K., Basic fibroblast growth factor (bFGF, FGF-2) immunoreactivity exists in the noradrenaline, adrenaline and 5-HT nerve cells of the rat brain, Neurosci. Lett., 160 (1993) 171-176.
3. 2+ responses to AMPA and NMDA in hippocampal neurons, J. Neurochem., 65 (1995) 2525-2536.
4. Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I. and Giménez-Gallego, G., Hypotensive activity of fibroblast growth factor, Science, 254 (1991) 1208-1210.
5. Cuevas, P., Revilla, C., Herreras, O., Largo, C. and Giménez-Gallego, G., Neuroprotective effect of acidic fibroblast growth factor on seizure-associated brain damage, Neurol. Res., 16 (1994) 365-369.
6. Czech, K.A. and Sagen, J., Update on cellular transplantation into the CNS as a novel theraphy for chronic pain, Prog. Neurobiol., 46 (1995) 507-529.
7. D'Amour, F.E. and Smith, D.L., A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-79.
8. Duarte, E.D.G., Lorenzetti, B.B. and Ferreira, S.H., Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway, Eur. J. Pharmacol., 186 (1990) 289-293.
9. Elde, R., Cao, Y., Cintra, A., Brelje, T.C., Pelto, H.M., Junttila, T., Fuxe, K., Pettersson, R.F. and Hökfelt, T., Prominent expression of acidic fibroblast growth factor in motor and sensory neurons, Neuron, 7 (1991) 349-364.
10. Fallon, J.H., Di Salvo, J., Loughlin, S.E., Giménez-Gallego, G., Serrogy, K.B., Bradshaw, R.A., Morrison, R.S., Ciofi, P. and Thomas, K.A., Localization of acidic fibroblast growth factor within the mouse brain using biochemical and immunocyto-chemical techniques, Growth Factors, 6 (1992) 139-157.
11. Giménez-Gallego G., and Cuevas, P., Fibroblast growth factors, proteins with a broad spectrum of biological activities, Neurol. Res., 16 (1994) 181-183.
12. Gonzalez, A.M., Logan, A., Ying, W., Lappi, D.A., Berry, M. and Baird, A., Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor, Endocrinology, 134 (1994) 2289-2297.
13. Guaza, C., Garcia-Andrés, C., Sandi, C., Muñoz-Willery, I., Cuevas, P. and Giménez-Gallego, G., Fibroblast growth factor decreases locomotor activity in rats, Neuroscience, (1996) in press.
14. Ikeda, K., Iwasaki, Y., Tagaya, N., Shiojima, T., Kobayashi, T. and Kinoshita, M., Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease, Neurol. Res., 17 (1995) 445-448.
15. Kumar, A., Raghubir, R. and Srimal Dhawan, B.N., Evidence for involvement of nitric oxide in pretectal analgesia in rat, NeuroReport, 4 (1993) 706-708.
16. Laird, J.M.A., Mason, G.S., Thomas, K.A., Hargreaves, R.J. and Hill, R.G., Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat, Neuroscience, 65 (1995) 209-216.
17. Matsuyama, A., Iwata, H., Okumura, N., Yoshida, S., Imaizumi, K., Lee, Y., Shiraishi, S. and Shiosaka, S., Localization of basic fibroblast growth factor-like immunoreactivity in the rat brain, Brain Res., 587 (1992) 49-65.
18. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons, J. Neurochem. 5, (1995) 1740-1751.
19. Meller, S.T., Lewis, S.J., Bates, J.N., Brody, M.H. and Gebbart, G.F., Is there a role for an endothelium-derived relaxing factor in nociception? Brain Res., 531 (1990) 342-345.
20. Ortega, S., Garcia, J.L., Zazo, M., Varela, J., Muñoz-Willery, I., Cuevas, P. and Giménez-Gallego, G., Single-step purification on DEAE-sephacel of recombinant polypeptides produced in Escherichia coli, Biotechnology, 10 (1992) 795-798.
21. Plata-Salaman, C.R., Growth factors, feeding regulation and the nervous system, Life Sci., 45 (1989) 1207-1212.
22. Sensenbrenner, M., The neurotrophic activity of fibroblast growth factors, Prog. Neurobiol., 41 (1993) 683-704.
23. Unsicker, K., The trophic cocktail made by adrenal chromaffin cells, Exp. Neurol., 123 (1993) 167-173.
24. Vaquero, J., Arias, A., Oya, S. and Zurita, M., Chromaffin cell allografts in the arachnoid of spinal cord reduce basal pain responses in rats, NeuroReport, 2 (1991) 149-151.
25. Yaksh, T.L. and Rudy, T.A., Studies on the direct spinal action of narcotics in the production of analgesia in the rat, J. Pharmacol. Exp. Ther., 202 (1977) 411-428.
26. Zhuo, M., Meller, S.T. and Gebhart, G.F., Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission, Pain, 54 (1993) 71-78.
27. Zazo, M., Lozano, R.M., Ortega, S., Varela, J., Diaz-Orejas, R., Ramirez, J.M. and Giménez-Gallego, G., High-level synthesis in Escherichia coli of shortened and full-length human acidic fibroblast growth factor and purification in a form stable in aqueous solutions, Gene, 13 (1992) 231-238.
28. Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals, Pain, 16 (1983) 109-110.